Related Experiment Video
Updated: Nov 16, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Comparison of COVID-19 and influenza characteristics
1Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Insights
Differentiating coronavirus disease 2019 (COVID-19) from influenza is crucial due to different treatments. Early-stage clinical and epidemiological characteristics are key to distinguishing these respiratory infections.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Coronavirus disease 2019 (COVID-19) emerged in December 2019, coinciding with the influenza season, posing global health and economic threats.
- Accurate differentiation between COVID-19 and influenza is essential due to distinct treatments and prognoses.
- Similarities between COVID-19 and influenza necessitate careful early-stage diagnosis.
Purpose of the Study:
- To compare the biological characteristics, epidemiology, clinical manifestations, pathological mechanisms, treatments, and prognostic factors of COVID-19 and influenza.
- To identify key differences and similarities to aid in the early-stage differentiation of these two respiratory infections.
- To provide guidance for the treatment and prevention of COVID-19 based on experiences from other epidemics.
Main Methods:
- Systematic review of official documents and news from health organizations (e.g., WHO, CDC).
- Comprehensive literature search across multiple databases (PubMed, Web of Science, Embase, CNKI, Wanfang, bioRxiv, medRxiv) up to October 3rd, 2020.
- Comparative analysis of gathered information on COVID-19 and influenza.
Main Results:
- COVID-19 and influenza share numerous similarities, complicating differentiation.
- Nucleic acid-based polymerase chain reaction (PCR) and antibody-based approaches are important diagnostic tools.
- Distinguishing between COVID-19 and influenza requires careful consideration of early-stage characteristics.
Conclusions:
- Clinicians and epidemiologists must utilize early-stage characteristics to differentiate COVID-19 from influenza.
- Leveraging insights from past epidemics can enhance the management and prevention strategies for COVID-19.
- Accurate early diagnosis is critical for effective public health response and patient outcomes.
Abstract:
The emergence of coronavirus disease 2019 (COVID-19) not only poses a serious threat to the health of people worldwide but also affects the global economy. The outbreak of COVID-19 began in December 2019, at the same time as the influenza season. However, as the treatments and prognoses of COVID-19 and influenza are different, it is important to accurately differentiate these two different respiratory tract infections on the basis of their respective early-stage characteristics. We reviewed official documents and news released by the National Health Commission of the People's Republic of China, the Chinese Center for Disease Control and Prevention (China CDC), the United States CDC, and the World Health Organization (WHO), and we also searched the PubMed, Web of Science, Excerpta Medica database (Embase), China National Knowledge Infrastructure (CNKI), Wanfang, preprinted bioRxiv and medRxiv databases for documents and guidelines from earliest available date up until October 3rd, 2020. We obtained the latest information about COVID-19 and influenza and summarized and compared their biological characteristics, epidemiology, clinical manifestations, pathological mechanisms, treatments, and prognostic factors. We show that although COVID-19 and influenza are different in many ways, there are numerous similarities; thus, in addition to using nucleic acid-based polymerase chain reaction (PCR) and antibody-based approaches, clinicians and epidemiologists should distinguish between the two using their respective characteristics in early stages. We should utilize experiences from other epidemics to provide additional guidance for the treatment and prevention of COVID-19.
Related Concept Videos
Leaky Scanning
Viral Mutations
Viral Recombination
Viruses with RNA Genomes

